Article
Genetics and Hemostatic Potential in Persons with Mild to Moderate Hemophilia A with a Discrepancy between One-Stage and Chromogenic FVIII Assays.
Thrombosis and haemostasis - 1 Jan 2021
Strålfors Annelie, Mikovic Danijela, Schmidt David, Onelöv Liselotte, Soutari Nida Mahmoud Hourani, Berndtson Maria, Chaireti Roza, Holmström Margareta, Antovic Jovan P, Bruzelius Maria
Abstract excerpt
BACKGROUND: Factor VIII (FVIII) activity (FVIII:C) can be measured by different methods including one-stage clotting assays (OSAs) and chromogenic assays (CSAs). Discrepancy between FVIII:C assays is known and associated with genetic variations causing mild and moderate hemophilia A (HA). We aimed to study the discrepancy phenomenon and to identify associated genetic alterations. Further, we investigated if...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
